© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Prevention

New HIV Vaccine Prompts Powerful Antibody Response in Animals
#PrEP
#Cure

Among English Gay & Bi Men, Hep C Is Increasingly Seen in Those Without HIV

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Arizona Repeals “No Promo Homo” Law That Hindered HIV Education

The anti-LGBT law barred students from getting medically accurate information about safe sex.

Gilead Requests Approval of Descovy for PrEP

Descovy and Truvada were both highly effective and generally safe options for HIV prevention in a recent clinical trial.

National Youth HIV & AIDS Awareness Day 2019

About 60 percent of young people living with HIV don’t know their status.

Circumcision Tied to Lower HIV Risk in Men Who Have Sex With Men

However, this finding applied only to those in low- and middle-income nations.

Georgia and Idaho Legalize Needle Exchanges to Stop HIV and Hep C

“This is a step in the right direction, but more work needs to be done.”

MUST read

Safer Sex
drug users passing a syringe
Safer Injecting
Treatment-as-Prevention (TasP)

Hep C Epidemic in French Gay & Bi Men Now Includes Those With & Without HIV

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

People Who Obtain PrEP Without a Prescription May Not Use It Correctly

Informal PrEP users were more likely to take it intermittently and skip recommended medical tests.

Unraveling the Mysteries of U.S. Drug Pricing

Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?

Trump Admin’s Goal for Slashing the HIV Rate Is Likely Unrealistic

The new federal plan to combat HIV has the audacious goal of cutting the annual infection rate by 90 percent by 2030.

Prevention: Antibody Vaccine

Researchers were also able to make the first-ever estimate of the level of antibodies needed for protection against HIV.

AIDS WATCH: Why Is the CDC Withholding Billions in PrEP Profits?

The CDC holds the patents to Truvada-as-PrEP, but hasn’t asked for a dime in royalties from Gilead. This is costing taxpayers billions. Why?
Pre-Exposure Prophylaxis (PrEP)

CDC Has Patents on PrEP, Advocates Find

Activists want future and retroactive royalties to pay for a national PrEP program.

Who’s Using PrEP in New York State?

We take a look at the first-ever release of comprehensive region-level PrEP use data in New York.

CROI 2019: So Much More Than an HIV Cure Extravaganza

The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.

Those Harboring Stigma Toward PrEP May Be Less Likely to Take It

A study of young gay and bi men and trans women in Chicago found PrEP stigma was linked with lower rates of use of Truvada for prevention.
Advertisement
Features
Opinions